Children’s Mental Health Awareness Day
May 7, 2026
At NEI, we are committed to supporting the clinicians who care for ...
Read More
Choosing an Adjunctive Antipsychotic for Major Depressive Disorder
May 6, 2026
Most patients with major depressive disorder (MDD) do not achieve f...
Read More
FDA Approves Dextromethorphan-Bupropion for Treatment of Agitation in Alzheimer Disease
April 30, 2026
The U.S. Food and Drug Administration has approved oral dextrometho...
Read More
Recommendations for the Deprescribing of Psychotropic Medications
April 29, 2026
Psychotropic polypharmacy is common, yet there has been limited gui...
Read More
Sleep EEG Brain Age Emerges as Possible Early Marker for Dementia Risk
April 27, 2026
Sleep disturbances are increasingly recognized as early indicators ...
Read More
Predicting Substance Use Behaviors with Machine Learning
April 24, 2026
In a recent study, researchers used a small set of variables and ma...
Read More
A Review of Evidence Reveals Minimal Support for Cannabinoids in Psychiatric Care
April 20, 2026
Cannabinoids are increasingly promoted and used for the treatment o...
Read More
Efficacy of the Neuroplastogen TSND-201 for the Treatment of PTSD
April 17, 2026
Posttraumatic stress disorder (PTSD) is a chronic and disabling psy...
Read More
Psilocybin Shows Greater Efficacy Than Nicotine Patches in Smoking Cessation Pilot Trial
April 13, 2026
More than two-thirds of U.S. smokers want to quit, but available tr...
Read More
Esketamine for Depressed Adolescents at Imminent Suicide Risk
April 7, 2026
Adolescents with depression have approximately a fivefold increased...
Read More
Clozapine After Failed Drug Trial in First-Episode Psychosis
April 6, 2026
Antipsychotic treatment algorithms in first-episode psychosis (FEP)...
Read More
From Awareness to Action: World Bipolar Day
March 30, 2026
World Bipolar Day is celebrated each year on March 30th. World Bipo...
Read More